secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001214659-25-014818
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro issues 361,743 shares on Series B Preferred conversion
---------------------------------------------------------------------

- Between Oct 1-8, 2025, 361,743 shares issued upon conversion of ~839.2 Series B Convertible Preferred shares.
- Shares issued under Section 4(a)(2) exemption from registration.
- As of Oct 8, 2025, total common shares outstanding: 3,801,604.
- Conversion increases outstanding share count by roughly 10.5% from prior level.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014818/0001214659-25-014818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925014818/o1082528k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-014818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer